Clinical Scorecard: Creation and internal assessment of a synergy score for inflammation and platelets in anterior circulation stroke: an exploratory case-control analysis

At a Glance

Key Highlights

• Synergy score incorporates CRP, MPV, PDW, platelet count, IMT, and unstable plaque status.
• Good discriminative ability demonstrated (AUC = 0.824).
• Cerebral infarction prevalence increased from 36.0% in low-risk to 87.2% in high-risk groups.
• Higher scores associated with greater stroke severity and unfavorable functional outcomes.

Guideline-Based Recommendations

Diagnosis

• Utilize the inflammation-platelet synergy score for distinguishing anterior circulation cerebral infarction from controls.

Management

• Consider risk stratification based on the synergy score.

Monitoring & Follow-up

• Assess CRP, MPV, PDW, platelet count, IMT, and unstable plaque status.

Risks

• Higher synergy scores correlate with increased stroke severity and poorer outcomes.

Patient & Prescribing Data

203 patients with anterior circulation cerebral infarction and 98 high-risk controls.

Preliminary findings require prospective validation before clinical application.

Clinical Best Practices

• Incorporate routine inflammatory and platelet markers in stroke risk assessment.
• Evaluate plaque morphology alongside traditional risk factors.

Related Resources & Content

• Global Burden of Disease Study 2019
• CANTOS trial
• Emerging Risk Factors Collaboration